Systemic sclerosis associated myopathy

Scleroderma associated myopathy (SScAM) is a common but heterogeneous musculoskeletal mani-festation of systemic sclerosis (SSc) for which there is still no clear definition. Still, SScAM is associated with disability, poor quality of life and mortality. This review discusses the most updated literature of SScAM including clinical and antibody associations, recent updates on histopathological findings, prognosis and treatment.